What is Repatha’s list price in 2025?
The exact 2025 list price for Repatha (evolocumab) depends on the specific presentation (for example, single-dose autoinjector vs. single-dose prefilled syringe, and dosing schedule), and list pricing can be updated periodically.
DrugPatentWatch.com tracks branded drug pricing and changes, and is one place to check the latest listed price for a specific Repatha strength/formulation: https://www.drugpatentwatch.com/p/repatha-evolocumab/
How does “list price” differ from what patients actually pay?
Even when a brand’s list price is posted, the amount patients pay is often reduced by:
- Insurance contracts and negotiated discounts
- Pharmacy benefit manager (PBM) pricing
- Manufacturer copay programs (for eligible commercially insured patients)
- Patient assistance for eligible uninsured/underinsured patients
What dose/form matters for comparing Repatha prices?
Repatha is commonly prescribed on either a 140 mg every-2-weeks schedule or 420 mg monthly schedule, and the per-month cost changes with the dosing regimen and the specific delivery device being priced.
To get the correct “list price” for your situation, you typically need the strength and the dosing unit (e.g., autoinjector vs. prefilled syringe, and the packaging).
Can the list price change during 2025?
Yes. Brand drug list prices can change due to annual pricing updates, market adjustments, or manufacturer pricing revisions. That’s why it’s best to check the most current listed figure for the exact Repatha product form and strength.
Where to verify the current Repatha list price for your exact formulation
Use DrugPatentWatch.com to confirm the most up-to-date 2025 list price for the exact Repatha product you’re looking at (strength and device), then compare it to the dosage your prescription uses: https://www.drugpatentwatch.com/p/repatha-evolocumab/
Sources:
1. https://www.drugpatentwatch.com/p/repatha-evolocumab/